Skip to main content
. 2019 Jul 31;20(15):3747. doi: 10.3390/ijms20153747

Figure 8.

Figure 8

Illustrative scheme for the bioavailability of DPSC-CM that can improve neuroinflammation, impaired microcirculation, and motor dysfunction. Our established aSAH model has exhibited impaired microcirculation and motor dysfunction that recapitulates the clinical symptoms of aSAH. DPSC-CM carries promising efficacy that can improve impaired microcirculation and various neurological deficits in this aSAH model.